IP Library Granted Patent US 12683021
Granted Patent B2
US 12683021 · App. 16/706,425 · Granted Jul 14, 2026

Methods and systems for promoting glucose management

Inventors: Apurv Ullas Kamath (San Diego, CA); Jack Pryor (Ladera Ranch, CA); Alexandra Lynn Carlton (San Marcos, CA); Kristin Koenekamp Cote (Walnut Creek, CA); Leif N. Bowman (San Diego, CA); Michael Robert Mensinger (San Diego, CA)
Assignee: Dexcom, Inc.
G16H40/67A61B5/0004A61B5/14532A61B5/14546A61B5/1495A61B5/4833A61B5/725A61B5/743A61B5/744A61B5/746A61B5/7475A61M5/142A61M5/1723G16H40/63A61M2205/3303A61M2205/502A61M2205/581A61M2205/582A61M2205/583A61M2230/06A61M2230/201A61M2230/63G16H20/17G16H50/50Y02A90/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12683021
App. No.
16/706,425
Granted
Jul 14, 2026
Kind
B2
Abstract

Methods and systems for encouraging interactions with a glucose monitoring system include incrementing a score and/or providing a reward based on a variety of different interactions with the glucose monitoring system. The interactions which improve the score may include initiating or changing displays, downloading data, setting operational parameters and other interactions that are independent of a user's glucose measurements. Encouraging these interactions can enhance success in maintaining healthy glucose concentrations.

Claims (15)

1 . A method of using a continuous analyte monitoring system, the method comprising:

receiving sensor data from a continuous analyte sensor worn by a patient, the sensor data indicative of glucose concentration values of the patient over a time period;

determining that the glucose concentration values fell outside of and returned to a glucose concentration range of the patient during the time period;

determining a first metric associated with the glucose concentration values falling outside and returning to the glucose concentration range during the time period, the first metric including a duration of time during which the glucose concentration values fell outside of the glucose concentration range;

determining that the first metric exceeds a first metric threshold by a first amount;

applying a first weight to the first amount that the first metric exceeds the first metric threshold;

determining a second metric associated with the glucose concentration values falling outside and returning to the glucose concentration range during the time period, the second metric including an amplitude of the glucose concentration values while outside of the glucose concentration range;

determining that the second metric exceeds a second metric threshold by a second amount;

applying a second weight to the second amount that the second metric exceeds the second metric threshold, where the second weight is different from the first weight;

determining a first type of reward for the patient using the weighted first amount and the weighted second amount; and

displaying or transmitting the first type of reward to the patient.

2 . The method of claim 1 , wherein the second metric threshold comprises a threshold amplitude.

3 . The method of claim 1 , wherein the first metric threshold comprises a threshold time duration.

4 . The method of claim 1 , wherein the first metric comprises a percentage of time the glucose concentration values fell outside of the glucose concentration range during the time period, and wherein the first metric threshold comprises a threshold time percentage.

5 . The method of claim 1 , wherein the first type of reward is included in a plurality of reward types, and a second type of reward corresponds to the glucose concentration values not falling outside and returning to the glucose concentration range during the time period.